| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/14/2009 | US7517673 Process for producing alpha1,4-galactosyltransferase and galactose-containing complex carbohydrate |
| 04/14/2009 | US7517672 Nucleic acids encoding mammalian T-type calcium channels |
| 04/14/2009 | US7517670 Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity |
| 04/14/2009 | US7517668 Process for the production of protein products in aspergillus |
| 04/14/2009 | US7517659 Comprises nucleotide sequences coding tandem of P domains in a weak inward rectifying potassium channel (TWIK) for identifying modulators and treatment of pain and headache disorders |
| 04/14/2009 | US7517658 Drug screening for human SNORF33 receptor agonist by contacting cells transfected with and expressing DNA encoding the human SNORF33 receptor, wherein cells prior to being transfected with the DNA do not express the human SNORF33 receptor; inflammation, infections, arthritis; autoimmune diseases |
| 04/14/2009 | US7517655 Protein capable of deposition onto extracellular matrix |
| 04/14/2009 | US7517651 Materials and methods for detection of nucleic acids |
| 04/14/2009 | US7517649 Contacting a sample with a nucleic acid molecule encoding OGFr and determining the level of the mRNA encoding said OGFr; antisense molecules, expression vectors and host cells, and proteins; anticarcinogenic and wound healing agents; drug screening |
| 04/14/2009 | US7517647 Screening retroviral cDNA library to identify transforming growth factor activator for use tool in prevention and treatment of cell proliferative and inflammatory disorders |
| 04/14/2009 | US7517646 Provides functional molecule having an affinity and specificity to a target comparable to the affinity and specificity of an antibody against an antigen; modified oligonucleotide sequence |
| 04/14/2009 | US7517643 Compounds displayed on replicable genetic packages and methods of using same |
| 04/14/2009 | US7517533 Pseudomonas aeruginosa antigens |
| 04/14/2009 | US7517531 Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4 |
| 04/14/2009 | US7517526 Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enhancing agents |
| 04/14/2009 | US7517523 Anti-MIF antibodies |
| 04/14/2009 | US7517520 Packaging of immunostimulatory oligonucleotides into virus-like particles: method of preparation and use |
| 04/14/2009 | CA2439182C Novel calcium-independent phospholipases a2, genes thereof and promoter of the same |
| 04/14/2009 | CA2371672C A method for the determination of a nucleic acid using a control |
| 04/14/2009 | CA2321215C Hybrid adenovirus-aav virus and method of use thereof |
| 04/14/2009 | CA2318576C Antibodies, including fv molecules, and immunoconjugates having high binding affinity for mesothelin and methods for their use |
| 04/14/2009 | CA2307175C Modified vitamin k-dependent polypeptides |
| 04/14/2009 | CA2304980C Immunoassay to detect herpesvirus specific igm |
| 04/14/2009 | CA2277583C Large scale genotyping of diseases and a diagnostic test for spinocerebellar ataxia type 6 |
| 04/14/2009 | CA2259657C Identification of a transforming fragment of herpes simplex type 2 and detection thereof in clinical specimens |
| 04/14/2009 | CA2208237C Nuclear protein serine/threonine kinases |
| 04/14/2009 | CA2201887C Patched genes and their use |
| 04/14/2009 | CA2130900C Therapeutic domains of von willebrand factor |
| 04/09/2009 | WO2009046464A1 Articular cartilage gene therapy with recombinant vector encoding bmp-7 |
| 04/09/2009 | WO2009046426A2 Compounds and methods for improving cellular uptake of oligomeric compounds |
| 04/09/2009 | WO2009046397A2 Modulating gene expression with agrna and gapmers targeting antisense transcripts |
| 04/09/2009 | WO2009046384A1 Methods for transferring molecular substances into plant cells |
| 04/09/2009 | WO2009046291A2 Laboratory-selected colonies of western corn rootworm with increased tolerance to maize containing event das-59122-7 and methods of use |
| 04/09/2009 | WO2009046248A1 Peroxisome biogenesis factor protein (pex) disruptions for altering the content of polyunsaturated fatty acids and the total lipid content in oleaginous eukaryotic organisms |
| 04/09/2009 | WO2009046231A1 Optimized strains of yarrowia lipolytica for high eicosapentaenoic acid production |
| 04/09/2009 | WO2009046220A2 Lipopeptides for delivery of nucleic acids |
| 04/09/2009 | WO2009046123A2 Nlrr-1 antagonists and uses thereof |
| 04/09/2009 | WO2009046006A1 Compositions and methods for altering alpha- and beta-tocotrienol content using multiple transgenes |
| 04/09/2009 | WO2009045898A2 Assessing t cell repertoires |
| 04/09/2009 | WO2009045813A1 Materials and methods for the delivery of biomolecules to cells of an organ |
| 04/09/2009 | WO2009045632A2 Nucleic acid based fluorescent sensor for mercury detection |
| 04/09/2009 | WO2009045627A2 Xylanases, nucleic acids encoding them and methods for making and using them |
| 04/09/2009 | WO2009045617A1 Porcine umami taste receptors and uses therefor |
| 04/09/2009 | WO2009045581A2 Bacteriophage with enhanced lytic activity |
| 04/09/2009 | WO2009045550A2 System for capturing and modifying large pieces of genomic dna and constructing organisms with synthetic chloroplasts |
| 04/09/2009 | WO2009045469A2 Increasing erythropoietin using nucleic acids hybridizable to micro-rna and precursors thereof |
| 04/09/2009 | WO2009045457A2 Tripartite rnai constructs |
| 04/09/2009 | WO2009045421A1 Method of contraception |
| 04/09/2009 | WO2009045370A2 Therapeutic gene-switch constructs and bioreactors for the expression of biotherapeutic molecules, and uses thereof |
| 04/09/2009 | WO2009045356A2 Microrna compositions in the treatment of vegf-mediated disorders |
| 04/09/2009 | WO2009045292A1 Sensitive and rapid methods of using chimeric receptors to identify autoimmune disease |
| 04/09/2009 | WO2009045179A1 Taz/wwtr1 for diagnosis and treatment of cancer |
| 04/09/2009 | WO2009045145A1 Novel compounds for the treatment or alleviation of edema, and methods for their use |
| 04/09/2009 | WO2009044868A1 Bacterium capable of fermenting glucose, mannose and xylose simultaneously, and method for production of bioethanol using the bacterium |
| 04/09/2009 | WO2009044793A1 siRNA TARGETING ONCOGENE |
| 04/09/2009 | WO2009044782A1 Method for synthesis of single- or double-stranded dna, and kit for the synthesis |
| 04/09/2009 | WO2009044773A1 Primer for amplification of rrna of bacterium belonging to the genus legionella, detection method, and detection kit |
| 04/09/2009 | WO2009044722A1 Gene susceptible to disease associated with intervertebral disc degeneration and use thereof |
| 04/09/2009 | WO2009044561A1 ANTI-proNT/NMN MONOCLONAL ANTIBODY |
| 04/09/2009 | WO2009044553A1 Method for screening of therapeutic agent for anemia |
| 04/09/2009 | WO2009044531A1 Method for producing β-amino acid |
| 04/09/2009 | WO2009044383A1 Nucleic acid codifying for a utrophin transcription specific regulating protein, protein codified thereby and uses thereof |
| 04/09/2009 | WO2009044294A2 Means and methods for the treatment of cataract and presbyopia |
| 04/09/2009 | WO2009044208A1 Protein |
| 04/09/2009 | WO2009044173A2 Methods of treating cancer using notch pathway inhibitors |
| 04/09/2009 | WO2009044158A2 Inhibitors and uses |
| 04/09/2009 | WO2009044154A2 Transcription factor decoys, compositions and methods |
| 04/09/2009 | WO2009044153A2 Inhibitors and uses |
| 04/09/2009 | WO2009044085A2 Oligonucleotides, use, method of detection and kit for diagnosing the presence of the e1 gene of the chikungunya virus |
| 04/09/2009 | WO2009043959A1 Method for identifying patients with sporadic burkitt's lymphoma, identification method and use of compounds for the treatment of sporadic burkitt's lymphoma |
| 04/09/2009 | WO2009043942A1 New polypeptides and uses thereof in cancer therapy |
| 04/09/2009 | WO2009043936A1 Widespread gene delivery to motor neurons using peripheral injection of aav vectors |
| 04/09/2009 | WO2009043922A2 Extracellular targets for alzheimer's disease |
| 04/09/2009 | WO2009043921A1 Attenuated invasive e. coli strains and applications thereof as intracellular vector for therapeutic molecule |
| 04/09/2009 | WO2009043759A2 Short rna antagonist compounds for the modulation of hif1alpha |
| 04/09/2009 | WO2009043565A1 Method for identifying the interaction partner of an active agent |
| 04/09/2009 | WO2009043354A2 Combination treatment for the treatment of hepatitis c virus infection |
| 04/09/2009 | WO2009043353A2 Micromirs |
| 04/09/2009 | WO2009043277A1 Skin care composition containing hsa fusion protein, method for preparation and use thereof |
| 04/09/2009 | WO2009043184A1 Nucleotide modular assemblies and their use as delivery devices |
| 04/09/2009 | WO2009043182A1 Sequence-characterized amplified region (scar) markers for plant resistance against fungal pathogens |
| 04/09/2009 | WO2009043173A1 Cc2d2a gene mutations associated with joubert syndrome and diagnostic methods for identifying the same |
| 04/09/2009 | WO2009043163A1 Bacterial degradation of paralytic shellfish toxins |
| 04/09/2009 | WO2009043132A1 Genetic polymorphism of n-acetyltransferase 2 (nat2) and use in medicine. |
| 04/09/2009 | WO2009043096A1 Improved method for mutagenesis |
| 04/09/2009 | WO2009023855A3 Tetrahydropyran nucleic acid analogs |
| 04/09/2009 | WO2009023549A3 Vaccine against botulism |
| 04/09/2009 | WO2009023416A3 Cosmetic methods and compositions for repairing human skin |
| 04/09/2009 | WO2009023271A3 Kappa-carrageenase and kappa-carrageenase-containing compositions |
| 04/09/2009 | WO2009020337A3 A method for in vitro phosphorylation of trap of staphylococcus aureus and a method for screening the inhibitor of the trap phosphorylation |
| 04/09/2009 | WO2009019433A3 Fertilisation protein |
| 04/09/2009 | WO2009017803A3 Antisense microrna and uses therefor |
| 04/09/2009 | WO2009014766A3 Non-invasive recovery of rna and analysis of gene expression in skin |
| 04/09/2009 | WO2009012210A3 Ethanol-producing microorganisms and methods of using |
| 04/09/2009 | WO2009010460A3 Transgenic plants with increased stress tolerance and yield |
| 04/09/2009 | WO2009000099A3 Methods of modifying antibodies, and modified antibodies with improved functional properties |
| 04/09/2009 | WO2008157572A3 A method of treating abnormal angiogenesis via the bai family of proteins and their protein fragments |
| 04/09/2009 | WO2008155397A3 Molecular targets and compounds, and methods to identify the same, useful in the treatment of bone and joint degenerative diseases |
| 04/09/2009 | WO2008153927A3 Genes and uses for plant enhancement |
| 04/09/2009 | WO2008138904A3 Rna antagonist compounds for the modulation of her3 |